The relative risk of overall graft loss and acute rejection among African American renal transplant recipients is attenuated with advancing age

Clinical Transplantation

Volumn 25, Issue 5, 2011, Pages 721-730

  Schold, Jesse D ^a,b   Srinivas, Titte R ^a   Braun, William E ^a   Shoskes, Daniel A ^a   Nurko, Saul ^a   Poggio, Emilio D ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Acute rejection; African Americans; Graft survival; Kidney transplantation; Socioeconomic factors

Indexed keywords

ACUTE GRAFT REJECTION; ADULT; AFRICAN AMERICAN; AGED; AGING; ARTICLE; CAUCASIAN; FEMALE; FOLLOW UP; GRAFT FAILURE; GROUPS BY AGE; HUMAN; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; DELAYED GRAFT FUNCTION; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; YOUNG ADULT;

EID: 80054114715     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01343.x     Document Type: Article

References (35)

1. Burdick JF, Williams GM. What causes center effects in kidney transplantation. Ann Surg 1986: 203: 311.
2. Rostand SG, Kirk KA, Rutsky EA, Pate BA. Racial differences in the incidence of treatment for end-stage renal disease. N Engl J Med 1982: 306: 1276.
3. Freedman BI, Soucie JM, McClellan WM. Family history of end-stage renal disease among incident dialysis patients. J Am Soc Nephrol 1997: 8: 1942.
4. Freedman BI, Hicks PJ, Bostrom MA et al. Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int 2009: 75: 736.
5. Burroughs TE, Swindle J, Takemoto S et al. Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. Transplantation 2007: 83: 1027.
6. Eckhoff DE, Young CJ, Gaston RS et al. Racial disparities in renal allograft survival: a public health issue? J Am Coll Surg 2007: 204: 894.
7. Gaston RS. Factors affecting renal allograft survival in African Americans. Blood Purif 1996: 14: 327.
8. Hricik DE, Augustine JJ, Knauss TC et al. Long-term graft outcomes after steroid withdrawal in African American kidney transplant recipients receiving sirolimus and tacrolimus. Transplantation 2007: 83: 277.
9. Hwang AH, Cho YW, Cicciarelli J, Mentser M, Iwaki Y, Hardy BE. Risk factors for short- and long-term survival of primary cadaveric renal allografts in pediatric recipients: a UNOS analysis. Transplantation 2005: 80: 466.
10. Shah T, Kasravi A, Huang E et al. Risk factors for development of new-onset diabetes mellitus after kidney transplantation. Transplantation 2006: 82: 1673.
11. Butkus DE, Dottes AL, Meydrech EF, Barber WH. Effect of poverty and other socioeconomic variables on renal allograft survival. Transplantation 2001: 72: 261.
12. Curtis JJ. Kidney transplantation: racial or socioeconomic disparities? Am J Kidney Dis 1999: 34: 756.
13. Woodward RS, Page TF, Soares R, Schnitzler MA, Lentine KL, Brennan DC. Income-related disparities in kidney transplant graft failures are eliminated by Medicare's immunosuppression coverage. Am J Transplant 2008: 8: 2636.
14. Isaacs RB, Nock SL, Spencer CE et al. Racial disparities in renal transplant outcomes. Am J Kidney Dis 1999: 34: 706.
15. Young CJ, Gaston RS. African Americans and renal transplantation: disproportionate need, limited access, and impaired outcomes. Am J Med Sci 2002: 323: 94.
16. Young CJ, Kew C. Health disparities in transplantation: focus on the complexity and challenge of renal transplantation in African Americans. Med Clin North Am 2005: 89: 1003, ix.
17. Levey AS, Coresh J, Greene T et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007: 53: 766.
18. Hricik DE, Knauss TC, Bodziak KA et al. Withdrawal of steroid therapy in African American kidney transplant recipients receiving sirolimus and tacrolimus. Transplantation 2003: 76: 938.
19. Keith DS, Cantarovich M, Paraskevas S, Tchervenkov J. Recipient age and risk of chronic allograft nephropathy in primary deceased donor kidney transplant. Transpl Int 2006: 19: 649.
20. Meier-Kriesche HU, Ojo A, Magee JC et al. African-American renal transplant recipients experience decreased risk of death due to infection: possible implications for immunosuppressive strategies. Transplantation 2000: 70: 375.
21. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003: 3: 178.
22. Augustine JJ, Siu DS, Clemente MJ, Schulak JA, Heeger PS, Hricik DE. Pre-transplant IFN-gamma ELISPOTs are associated with post-transplant renal function in African American renal transplant recipients. Am J Transplant 2005: 5: 1971.
23. Gruber SA, Garnick J, Morawski K et al. Cytomegalovirus prophylaxis with valganciclovir in African-American renal allograft recipients based on donor/recipient serostatus. Clin Transplant 2005: 19: 273.
24. Schold JD, Rehman S, Kayle LK, Magliocca J, Srinivas TR, Meier-Kriesche HU. Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States. Transpl Int 2009: 22: 626.
25. Schold JD, Srinivas TR, Kayler LK, Meier-Kriesche HU. The overlapping risk profile between dialysis patients listed and not listed for renal transplantation. Am J Transplant 2008: 8: 58.
26. Abbott KC, Sawyers ES, Oliver JD III et al. Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis 2001: 37: 366.
27. Koyama H, Cecka JM, Terasaki PI. Kidney transplants in black recipients. HLA matching and other factors affecting long-term graft survival. Transplantation 1994: 57: 1064.
28. Woodward RS, Schnitzler MA, Lowell JA, Spitznagel EL, Brennan DC. Effect of extended coverage of immunosuppressive medications by medicare on the survival of cadaveric renal transplants. Am J Transplant 2001: 1: 69.
29. New Medicare Hosptial Conditions of Participation for Transplant Centers. Centers for Medicare and Medicaid Services. 12-23-2009. Available at
30. Braun WE. The rocky road of limited immunosuppression for renal transplantation in African Americans. Transplantation 2007: 83: 267.
31. Poggio ED, Nef PC, Wang X et al. Performance of the Cockcroft-Gault and modification of diet in renal disease equations in estimating GFR in ill hospitalized patients. Am J Kidney Dis 2005: 46: 242.
32. Meier-Kriesche HU, Srinivas TR, Kaplan B. Interaction between acute rejection and recipient age on long-term renal allograft survival. Transplant Proc 2001: 33: 3425.
33. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004: 4: 378.
34. Abe-Sandes K, Silva WA Jr, Zago MA. Heterogeneity of the Y chromosome in Afro-Brazilian populations. Hum Biol 2004: 76: 77.
35. Whaley AL. Ethnicity/race, ethics, and epidemiology. J Natl Med Assoc 2003: 95: 736.